BERKELEY, Calif., Jan. 26, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical company with three distinct immunotherapy technologies, announced today the appointment of five key opinion leaders to its scientific advisory board, who join four existing leading clinicians, researchers and scientists. Newly appointed members include: Thomas Gajewski, M.D., Ph.D., Darren Higgins, Ph.D., F. Stephen Hodi, M.D., Wiebe Olijve, Ph.D., and David H. Raulet, Ph.D. “We are...